Results 21 to 30 of about 569,278 (268)

Host DNA released by NETosis in neutrophils exposed to seasonal H1N1 and highly pathogenic H5N1 influenza viruses

open access: yesRespiratory Research, 2020
Background Neutrophil is of the most abundant number in human immune system. During acute influenza virus infection, neutrophils are already active in the early phase of inflammation - a time in which clinical biopsy or autopsy material is not readily ...
Louisa L. Y. Chan   +5 more
doaj   +1 more source

SARS-CoV-2 Reverse Zoonoses to Pumas and Lions, South Africa

open access: yesViruses, 2022
Reverse-zoonotic infections of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) from humans to wildlife species internationally raise concern over the emergence of new variants in animals.
Katja Natalie Koeppel   +5 more
doaj   +1 more source

Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial

open access: yesHuman Vaccines & Immunotherapeutics, 2020
An Escherichia. coli-produced HPV-16/18 bivalent vaccine has been proved to be well-tolerated and highly efficacious against diseases associated with vaccine HPV types.
Ying-Ying Su   +16 more
doaj   +1 more source

Epidemiology of Shuni Virus in Horses in South Africa

open access: yesViruses, 2021
The Orthobunyavirus genus, family Peribunyaviridae, contains several important emerging and re-emerging arboviruses of veterinary and medical importance.
Thopisang P. Motlou   +2 more
doaj   +1 more source

Respiratory virus infections

open access: yesPaediatric Respiratory Reviews, 2007
The respiratory tract is a frequent site of infection with a wide range of viruses. Each family of viruses can cause differing clinical syndromes depending on the age of the patient and the immune response. As a corollary, different clinical syndromes can be caused by different families of viruses.
openaire   +2 more sources

Heterologous booster vaccination enhances antibody responses to SARS-CoV-2 by improving Tfh function and increasing B-cell clonotype SHM frequency

open access: yesFrontiers in Immunology
Heterologous prime-boost has broken the protective immune response bottleneck of the COVID-19 vaccines. however, the underlying mechanisms have not been fully elucidated.
Yanli Song   +10 more
doaj   +1 more source

Respiratory syncytial virus

open access: yesUirusu, 2005
Human respiratory syncytial virus (RSV) is the most common worldwide cause of lower respiratory tract infections (LRI) in infants less than 6 months of age. The prophylaxis against RSV infection by vaccination has been unsuccessful because of its adverse effects.
openaire   +5 more sources

Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen

open access: yesHuman Vaccines & Immunotherapeutics
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal beta-coronavirus that emerged in 2012. The virus is part of the WHO blueprint priority list with a concerning fatality rate of 35%.
Rahul Ahuja   +11 more
doaj   +1 more source

Respiratory syncytial virus infections [PDF]

open access: yesPostgraduate Medical Journal, 1973
Summary RS virus was isolated from 10·5% of the specimens examined in the MRC/PHLS hospital survey and from 0·9% of those in the general practice survey. The highest isolation rates were in infants with lower respiratory tract infections. Dyspnoea, wheezing and cough were the predominant clinical features.
openaire   +2 more sources

3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor

open access: yesFrontiers in Pharmacology, 2021
The global spread of the novel coronavirus SARS-CoV-2 urgently requires discovery of effective therapeutics for the treatment of COVID-19. The spike (S) protein of SARS-CoV-2 plays a key role in receptor recognition, virus-cell membrane fusion and virus ...
Taizhen Liang   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy